Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

4.65
+0.36508.53%
Volume:938.08K
Turnover:4.04M
Market Cap:252.40M
PE:-1.29
High:4.79
Open:4.18
Low:4.02
Close:4.28
Loading ...
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Mar 24, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Mar 04, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Jan 15, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2024

Correspondence

Form CORRESP - Correspondence
Dec 02, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Oct 04, 2024

Major Issues Report

Form 8-K - Current report